Study Evaluating Safety and Efficacy of UCART123v1.2 in Patients With Relapsed/Refractory Acute Myeloid Leukemia

NCT03190278 · clinicaltrials.gov ↗
PHASE1
Phase
ACTIVE_NOT_RECRUITING
Status
29
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Cellectis S.A.